Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer

by Cattrini, Carlo, Bersanelli, Melissa, Latocca, Maria Maddalena, Conte, Benedetta, Vallome, Giacomo, Boccardo, Francesco
Published in Cancers (Basel) (2020)

Management of young women with early breast cancer

by Poggio, Francesca, Lambertini, Matteo, Bighin, Claudia, Conte, Benedetta, Blondeaux, Eva, D'Alonzo, Alessia, Dellepiane, Chiara, Boccardo, Francesco, Del Mastro, Lucia
Published in ESMO Open (2018)

Update on the Management of Breast Cancer during Pregnancy

by Poggio, Francesca, Tagliamento, Marco, Pirrone, Chiara, Soldato, Davide, Conte, Benedetta, Molinelli, Chiara, Cosso, Maurizio, Fregatti, Piero, Del Mastro, Lucia, Lambertini, Matteo
Published in Cancers (Basel) (2020)

Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis

by Poggio, Francesca, Bruzzone, Marco, Ceppi, Marcello, Conte, Benedetta, Martel, Samuel, Maurer, Christian, Tagliamento, Marco, Viglietti, Giulia, Del Mastro, Lucia, de Azambuja, Evandro, Lambertini, Matteo
Published in ESMO Open (2018)

Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review

by Poggio, Francesca, Lambertini, Matteo, Bighin, Claudia, Conte, Benedetta, Blondeaux, Eva, D’Alonzo, Alessia, Dellepiane, Chiara, Buzzatti, Giulia, Molinelli, Chiara, Boccardo, Francesco, Del Mastro, Lucia
Published in Clin Med Insights Reprod Health (2019)

Italian survey on managing immune checkpoint inhibitors in oncology during COVID‐19 outbreak

by Tagliamento, Marco, Spagnolo, Francesco, Poggio, Francesca, Soldato, Davide, Conte, Benedetta, Ruelle, Tommaso, Barisione, Emanuela, De Maria, Andrea, Del Mastro, Lucia, Di Maio, Massimo, Lambertini, Matteo
Published in Eur J Clin Invest (2020)

Breast Cancer Surgery in the COVID-19 Pandemic: Validation of a Preventive Program for Patients and Health Care Workers

by FREGATTI, PIERO, GIPPONI, MARCO, GIACCHINO, MARIA, SPARAVIGNA, MARCO, DIAZ, RAQUEL, FIORAVANTI, EMANUELA, CORNACCHIA, CHIARA, CONTE, BENEDETTA, LAMBERTINI, MATTEO, ZOPPOLI, GABRIELE, MURELLI, FEDERICA, LUISA TONI, MARIA, TERESA CALABRΟ, MARIA, ORSINO, LINA, FRIEDMAN, DANIELE
Published in In Vivo (2021)

Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study

by Blondeaux, Eva, Lambertini, Matteo, Michelotti, Andrea, Conte, Benedetta, Benasso, Marco, Dellepiane, Chiara, Bighin, Claudia, Pastorino, Simona, Levaggi, Alessia, Alonzo, Alessia D’, Poggio, Francesca, Buzzatti, Giulia, Molinelli, Chiara, Fregatti, Piero, Bertoglio, Sergio, Boccardo, Francesco, Del Mastro, Lucia
Published in Br J Cancer (2020)

Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Developmen...

by Dieci, Maria Vittoria, Del Mastro, Lucia, Cinquini, Michela, Montemurro, Filippo, Biganzoli, Laura, Cortesi, Laura, Zambelli, Alberto, Criscitiello, Carmen, Levaggi, Alessia, Conte, Benedetta, Calabrese, Massimo, Fiorentino, Alba, Marchiò, Caterina, Tinterri, Corrado, Fittipaldo, Veronica Andrea, Pappagallo, Giovanni, Gori, Stefania
Published in Cancers (Basel) (2019)

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

by Martínez-Sáez, Olga, Chic, Nuria, Pascual, Tomás, Adamo, Barbara, Vidal, Maria, González-Farré, Blanca, Sanfeliu, Esther, Schettini, Francesco, Conte, Benedetta, Brasó-Maristany, Fara, Rodríguez, Adela, Martínez, Débora, Galván, Patricia, Rodríguez, Ana Belén, Martinez, Antonio, Muñoz, Montserrat, Prat, Aleix
Published in Breast Cancer Res (2020)

Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis

by Schettini, Francesco, Giuliano, Mario, Giudici, Fabiola, Conte, Benedetta, De Placido, Pietro, Venturini, Sergio, Rognoni, Carla, Di Leo, Angelo, Locci, Mariavittoria, Jerusalem, Guy, Del Mastro, Lucia, Puglisi, Fabio, Conte, PierFranco, De Laurentiis, Michelino, Pusztai, Lajos, Rimawi, Mothaffar F., Schiff, Rachel, Arpino, Grazia, De Placido, Sabino, Prat, Aleix, Generali, Daniele
Published in Cancers (Basel) (2021)

Independent validation of the PAM50-based Chemo-Endocrine Score (CES) in hormonal receptor positive HER2-positive breast cancer treated with neoadjuvant anti-HER2-based therapy

by Pascual, Tomás, Fernandez-Martinez, Aranzazu, Tanioka, Maki, Dieci, M. Vittoria, Pernas, Sonia, Gavila, Joaquin, Guarnieri, Valentina, Cortes, Javier, Villagrasa, Patricia, Chic, Núria, Vidal, Maria, Adamo, Barbara, Muñoz, Montserrat, Griguolo, Gaia, Llombart, Antonio, Conte, Pierfranco, Oliveira, Mafalda, Conte, Benedetta, Paré, Laia, Galvan, Patricia, Carey, Lisa A., Perou, Charles M., Prat, Aleix
Published in Clin Cancer Res (2021)

Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy

by Martínez-Sáez, Olga, Pascual, Tomás, Brasó-Maristany, Fara, Chic, Nuria, González-Farré, Blanca, Sanfeliu, Esther, Rodríguez, Adela, Martínez, Débora, Galván, Patricia, Rodríguez, Anna Belén, Schettini, Francesco, Conte, Benedetta, Vidal, Maria, Adamo, Barbara, Martínez, Antoni, Muñoz, Montserrat, Moreno, Reinaldo, Villagrasa, Patricia, Salvador, Fernando, Ciruelos, Eva M., Faull, Iris, Odegaard, Justin I., Prat, Aleix
Published in NPJ Breast Cancer (2021)

Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer

by Schettini, Francesco, Chic, Nuria, Brasó-Maristany, Fara, Paré, Laia, Pascual, Tomás, Conte, Benedetta, Martínez-Sáez, Olga, Adamo, Barbara, Vidal, Maria, Barnadas, Esther, Fernández-Martinez, Aranzazu, González-Farre, Blanca, Sanfeliu, Esther, Cejalvo, Juan Miguel, Perrone, Giuseppe, Sabarese, Giovanna, Zalfa, Francesca, Peg, Vicente, Fasani, Roberta, Villagrasa, Patricia, Gavilá, Joaquín, Barrios, Carlos H., Lluch, Ana, Martín, Miguel, Locci, Mariavittoria, De Placido, Sabino, Prat, Aleix
Published in NPJ Breast Cancer (2021)

HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: a systematic review and meta-analysis

by Schettini, Francesco, Pascual, Tomas, Conte, Benedetta, Chic, Nuria, Brasó-Maristany, Fara, Galván, Patricia, Martínez, Olga, Adamo, Barbara, Vidal, Maria, Muñoz, Montserrat, Fernández-Martinez, Aranzazu, Rognoni, Carla, Griguolo, Gaia, Guarneri, Valentina, Conte, Pier Franco, Locci, Mariavittoria, Brase, Jan C., Gonzalez-Farre, Blanca, Villagrasa, Patricia, De Placido, Sabino, Schiff, Rachel, Veeraraghavan, Jamunarani, Rimawi, Mothaffar F., Osborne, C. Kent, Pernas, Sonia, Perou, Charles M., Carey, Lisa A., Prat, Aleix
Published in Cancer Treat Rev (2020)

Development of a multi-parameter prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation

by Prat, Aleix, Guarneri, Valentina, Paré, Laia, Griguolo, Gaia, Pascual, Tomás, Dieci, Maria Vittoria, Chic, Núria, González-Farré, Blanca, Frassoldati, Antonio, Sanfeliu, Esther, Cejalvo, Juan Miguel, Muñoz, Montserrat, Bisagni, Giancarlo, Brasó-Maristany, Fara, Urso, Loredana, Vidal, Maria, Brandes, Alba Ariela, Adamo, Barbara, Musolino, Antonino, Miglietta, Federica, Conte, Benedetta, Oliveira, Mafalda, Saura, Cristina, Pernas, Sònia, Alarcón, Jesús, Llombart-Cussac, Antonio, Cortés, Javier, Manso, Luis, López, Rafael, Ciruelos, Eva, Schettini, Francesco, Villagrasa, Patricia, Carey, Lisa A., Perou, Charles M., Piacentini, Federico, D’Amico, Roberto, Tagliafico, Enrico, Parker, Joel. S., Conte, Pierfranco
Published in Lancet Oncol (2020)